For the past 13 months, the once-hot marijuana industry has been ice cold. Following a first quarter in 2019 that saw more than a dozen pot stocks gain at least 70%, the vast majority of North American cannabis stocks have lost between 50% and 95% of their value ever since. To our north, regulatory issues are predominantly to blame, with Health Canada delaying the launch of high-margin derivatives by two months, and Ontario's provincial regulators dropping the ball on retail store licensing. Read More...
The 9 Best Marijuana Stocks in April
For the past 13 months, the once-hot marijuana industry has been ice cold. Following a first quarter in 2019 that saw more than a dozen pot stocks gain at least 70%, the vast majority of North American cannabis stocks have lost between 50% and 95% of their value ever since. To our north, regulatory issues are predominantly to blame, with Health Canada delaying the launch of high-margin derivatives by two months, and Ontario’s provincial regulators dropping the ball on retail store licensing.
Add Comment